Summary
Colgate-Palmolive Company reported a solid first quarter for 2012, with net sales increasing by 5.0% to $4.2 billion compared to the same period in 2011. This growth was driven by a combination of volume increases and strategic pricing, partially offset by unfavorable foreign exchange rates. Diluted earnings per share also saw a healthy increase to $1.23, up from $1.16 in the prior year, indicating improved profitability. The company's core Oral, Personal, and Home Care segment performed well, with notable growth in Latin America and Greater Asia/Africa. The acquisition of the Sanex business continued to contribute positively to sales. While raw material costs and certain one-time expenses impacted gross profit margins, the company's 'funding-the-growth' initiatives and pricing strategies helped to mitigate these pressures.
Financial Highlights
48 data points| Revenue | $4.20B |
| Cost of Revenue | $1.76B |
| Gross Profit | $2.44B |
| SG&A Expenses | $1.48B |
| Operating Income | $938.00M |
| Net Income | $593.00M |
| EPS (Basic) | $0.62 |
| EPS (Diluted) | $0.61 |
| Shares Outstanding (Basic) | 960.20M |
| Shares Outstanding (Diluted) | 967.80M |
Key Highlights
- 1Net sales increased by 5.0% to $4.2 billion in Q1 2012, driven by 3.5% volume growth and 3.5% price increases.
- 2Diluted Earnings Per Share (EPS) rose to $1.23 in Q1 2012, compared to $1.16 in Q1 2011, reflecting improved profitability.
- 3The Oral, Personal, and Home Care segment saw a 6.0% increase in net sales, with Latin America and Greater Asia/Africa showing robust growth.
- 4The Sanex acquisition, completed in June 2011, contributed positively to net sales and volume growth.
- 5Gross profit margin slightly decreased to 58.0% from 58.4% due to higher raw material costs, though offset by cost savings and pricing.
- 6Operating profit increased by 3% to $938 million, despite some costs related to business realignments and the sale of land in Mexico.
- 7Cash and cash equivalents increased by $166 million to $1,044 million by the end of Q1 2012.